Daniel Herranz
Daniel Herranz
Assistant Professor of Pharmacology, Rutgers Cancer Institute of New Jersey
Dirección de correo verificada de cinj.rutgers.edu - Página principal
TítuloCitado porAño
Sirt1 protects against high-fat diet-induced metabolic damage
PT Pfluger, D Herranz, S Velasco-Miguel, M Serrano, MH Tschöp
Proceedings of the national academy of sciences 105 (28), 9793-9798, 2008
8202008
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
D Herranz, M Muñoz-Martin, M Cañamero, F Mulero, B Martinez-Pastor, ...
Nature communications 1, 3, 2010
4882010
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
D Beiroa, M Imbernon, R Gallego, A Senra, D Herranz, F Villarroya, ...
Diabetes 63 (10), 3346-3358, 2014
2382014
SIRT1: recent lessons from mouse models
D Herranz, M Serrano
Nature Reviews Cancer 10 (12), 819, 2010
2302010
SIRT1 contributes to telomere maintenance and augments global homologous recombination
JA Palacios, D Herranz, ML De Bonis, S Velasco, M Serrano, MA Blasco
The Journal of cell biology 191 (7), 1299-1313, 2010
1942010
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
D Herranz, A Ambesi-Impiombato, T Palomero, SA Schnell, L Belver, ...
Nature medicine 20 (10), 1130, 2014
1862014
Sirtuin 1 regulation of developmental genes during differentiation of stem cells
V Calvanese, E Lara, B Suárez-Álvarez, RA Dawud, ...
Proceedings of the National Academy of Sciences 107 (31), 13736-13741, 2010
1452010
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia
E Piovan, J Yu, V Tosello, D Herranz, A Ambesi-Impiombato, AC Da Silva, ...
Cancer cell 24 (6), 766-776, 2013
1432013
Tumour biology: policing of oncogene activity by p53
A Efeyan, I Garcia-Cao, D Herranz, S Velasco-Miguel, M Serrano
Nature 443 (7108), 159, 2006
1372006
Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin
A Efeyan, A Ortega-Molina, S Velasco-Miguel, D Herranz, LT Vassilev, ...
Cancer Research 67 (15), 7350-7357, 2007
1212007
Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK
A Maraver, PJ Fernandez-Marcos, D Herranz, M Cañamero, ...
Cancer cell 22 (2), 222-234, 2012
982012
Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia
D Herranz, A Ambesi-Impiombato, J Sudderth, M Sánchez-Martín, ...
Nature medicine 21 (10), 1182, 2015
902015
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling
JL García‐Rodríguez, L Barbier‐Torres, S Fernández‐Álvarez, ...
Hepatology 59 (5), 1972-1983, 2014
662014
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency
D Herranz, A Maraver, M Canamero, G Gomez-Lopez, L Inglada-Perez, ...
Oncogene 32 (34), 4052, 2013
602013
SIRT1 stabilizes PML promoting its sumoylation
M Campagna, D Herranz, MA Garcia, L Marcos-Villar, ...
Cell death and differentiation 18 (1), 72, 2011
572011
Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer
E Wauters, VJSA Lobo, AV Pinho, A Mawson, D Herranz, J Wu, ...
Cancer research 73 (7), 2357-2367, 2013
422013
Free [NADH]/[NAD+] regulates sirtuin expression
J Gambini, MC Gomez-Cabrera, C Borras, SL Valles, R Lopez-Grueso, ...
Archives of biochemistry and biophysics 512 (1), 24-29, 2011
362011
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia
G Fabbri, AB Holmes, M Viganotti, C Scuoppo, L Belver, D Herranz, ...
Proceedings of the National Academy of Sciences 114 (14), E2911-E2919, 2017
342017
Acetylation is indispensable for p53 antiviral activity
C Muñoz-Fontela, D González, L Marcos-Villar, M Campagna, P Gallego, ...
Cell cycle 10 (21), 3701-3705, 2011
322011
Impact of Sirt1 on mammalian aging
D Herranz, M Serrano
Aging (Albany NY) 2 (6), 315, 2010
262010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20